Please assess the completion status of the following clinical trial:

Trial Title: Two Dose Regimens of Nifedipine for the Management of Preterm Labor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All pregnant women diagnosed with preterm labor defined as regular contractions associated with cervical change between 24 and 34 weeks of gestation~Exclusion Criteria:~* Multiple pregnancy~* Preterm rupture of membranes~* Congenital fetal malformations~* IUGR (intra uterine growth restriction)~* Previous tocolysis in this pregnancy~* Chorioamnionitis~* Cervical dilation \> 4 cms~* Maternal medical conditions such as renal insufficiency, hepatic insufficiency, or myasthenia gravis~* Non-reassuring fetal heart rate~* Maternal hypotension, defined as a blood pressure \< 90/50 mmHg

- Gender: FEMALE
- Minimum Age: 17 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- A (Type: OTHER): High dose Nifedpine arm
- B (Type: OTHER): Low dose Nifedipine arm

Based on this trial design, predict the completion outcome and termination type (if applicable).